Comment - Funding the elimination of viral hepatitis: donors needed

The Lancet Gastroenterology & Hepatology
Comment
Funding the elimination of viral hepatitis: donors needed
Charles Gore , Jessica Hicks, Wouter Deelder
Published: 31 October 2017

DOI: http://dx.doi.org/10.1016/S2468-1253(17)30333-3

PDF Download

Chronic hepatitis B and C are life-threatening infectious diseases that cause serious liver damage, cancer, and premature death. More than 300 million people are infected with hepatitis B or hepatitis C¹ and are at risk of developing escalating health problems. These infectious diseases cause 1·3 million deaths every year¹ and are responsible for more than half of all new cases of liver cancer and one in every 12 cancer deaths.² Whereas the burden of other major infectious diseases such as HIV, tuberculosis, and malaria is decreasing as a result of consistent large-scale global investment, viral hepatitis has been neglected, resulting in ever increasing numbers of people dying from hepatitis B and C...
http://www.thelancet.com/journals/langas/article/PIIS2468-1253(17)30333-3/fulltext